Biotech financing update: December 2018 to February 2019

Chris Molloy on the Labour Party conference; female biotech leaders in Edinburgh; Women in Biotech mentoring programme; Advanced Therapy Treatment Centre; BioSolutions Advisory Board; TechBio UK; and careers at BIA

Brainomix announced new data published in the esteemed American Journal of Respiratory & Critical Care Medicine (AJRCCM)

Poolbeg Pharma announces its unaudited interim results for the six months to 30 June 2026.

£135 million for two life sciences funds, rare disease R&D, Beacon Therapeutics, Basecamp Research’s Series C, Birmingham Life Sciences Week, Liberal Democrat party conference, Women in Biotech Edinburgh

Regional cluster updates, fresh OLS data, NICE's Enhertu approval and £89.9m for Chemify - catch up on this week's CEO blog.